These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 324261

  • 41. Comparative study of the anorexigenic activity of 5-(3,4-dichlorophenoxymethyl)-2-amino-2-oxazoline HCl and d-amphetamine in different species.
    Abdallah AH.
    Toxicol Appl Pharmacol; 1973 Jul; 25(3):344-53. PubMed ID: 4580493
    [No Abstract] [Full Text] [Related]

  • 42. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA.
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [Abstract] [Full Text] [Related]

  • 43. Reduced energy expenditure after ventromedial hypothalamic lesions in female rats.
    Vilberg TR, Keesey RE.
    Am J Physiol; 1984 Jul; 247(1 Pt 2):R183-8. PubMed ID: 6742229
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Effect of adrenalectomy on glucose tolerance and lipid metabolism in gold-thioglucose obese mice.
    Blair SC, Caterson ID, Cooney GJ.
    Am J Physiol; 1994 Jun; 266(6 Pt 1):E993-1000. PubMed ID: 8023932
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Robust Reductions of Excess Weight and Hyperphagia by Beloranib in Rat Models of Genetic and Hypothalamic Obesity.
    Elfers CT, Roth CL.
    Endocrinology; 2017 Jan 01; 158(1):41-55. PubMed ID: 27849360
    [Abstract] [Full Text] [Related]

  • 49. Metabolic responses to long-term pharmacological inhibition of CB1-receptor activity in mice in relation to dietary fat composition.
    Koolman AH, Bloks VW, Oosterveer MH, Jonas I, Kuipers F, Sauer PJ, van Dijk G.
    Int J Obes (Lond); 2010 Feb 01; 34(2):374-84. PubMed ID: 19844210
    [Abstract] [Full Text] [Related]

  • 50. Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice.
    Long RT, Zeng WS, Chen LY, Guo J, Lin YZ, Huang QS, Luo SQ.
    Int J Obes (Lond); 2010 Apr 01; 34(4):712-9. PubMed ID: 20065960
    [Abstract] [Full Text] [Related]

  • 51. Multi-hormonal weight loss combinations in diet-induced obese rats: therapeutic potential of cholecystokinin?
    Trevaskis JL, Turek VF, Griffin PS, Wittmer C, Parkes DG, Roth JD.
    Physiol Behav; 2010 May 11; 100(2):187-95. PubMed ID: 20206194
    [Abstract] [Full Text] [Related]

  • 52. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity.
    Air EL, Strowski MZ, Benoit SC, Conarello SL, Salituro GM, Guan XM, Liu K, Woods SC, Zhang BB.
    Nat Med; 2002 Feb 11; 8(2):179-83. PubMed ID: 11821903
    [Abstract] [Full Text] [Related]

  • 53. Regulatory effects of Y4 receptor agonist (BVD-74D) on food intake.
    Li JB, Asakawa A, Terashi M, Cheng K, Chaolu H, Zoshiki T, Ushikai M, Sheriff S, Balasubramaniam A, Inui A.
    Peptides; 2010 Sep 11; 31(9):1706-10. PubMed ID: 20600429
    [Abstract] [Full Text] [Related]

  • 54. Emodin protects against high-fat diet-induced obesity via regulation of AMP-activated protein kinase pathways in white adipose tissue.
    Tzeng TF, Lu HJ, Liou SS, Chang CJ, Liu IM.
    Planta Med; 2012 Jun 11; 78(10):943-50. PubMed ID: 22673833
    [Abstract] [Full Text] [Related]

  • 55. Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome.
    Madsen AN, Hansen G, Paulsen SJ, Lykkegaard K, Tang-Christensen M, Hansen HS, Levin BE, Larsen PJ, Knudsen LB, Fosgerau K, Vrang N.
    J Endocrinol; 2010 Sep 11; 206(3):287-96. PubMed ID: 20508079
    [Abstract] [Full Text] [Related]

  • 56. The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat.
    Hansen HH, Hansen G, Paulsen S, Vrang N, Mark M, Jelsing J, Klein T.
    Eur J Pharmacol; 2014 Oct 15; 741():254-63. PubMed ID: 25160746
    [Abstract] [Full Text] [Related]

  • 57. A model for antipsychotic-induced obesity in the male rat.
    Minet-Ringuet J, Even PC, Lacroix M, Tomé D, de Beaurepaire R.
    Psychopharmacology (Berl); 2006 Sep 15; 187(4):447-54. PubMed ID: 16783538
    [Abstract] [Full Text] [Related]

  • 58. Effects of goldthioglucose lesions on central catecholamine levels in the mouse.
    Lorden JF, Dawson R, Callahan M.
    Pharmacol Biochem Behav; 1979 Jan 15; 10(1):165-9. PubMed ID: 375245
    [Abstract] [Full Text] [Related]

  • 59. Hypophysectomy blocks the weight gain and obesity produced by goldthioglucose lesions.
    Powley TL, Plocher TA.
    Behav Neural Biol; 1980 Mar 15; 28(3):300-18. PubMed ID: 6767473
    [No Abstract] [Full Text] [Related]

  • 60. The induction of obesity in the rat with bipiperidyl mustard.
    Jagot SA, Webb GP, Rogers PD, Dickerson JW.
    Br J Nutr; 1980 Nov 15; 44(3):253-5. PubMed ID: 7437409
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.